St. Jude Medical, Inc. (STJ) Tops Q3 EPS by 2c, Guides In-Line; to Buyback $300M in Stock
Tweet
Share
E-mailGet Alerts STJ Hot Sheet
Join SI Premium – FREE
St. Jude Medical, Inc. (NYSE: STJ) reported Q3 EPS of $0.83, $0.02 better than the analyst estimate of $0.81. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.34 billion.
St. Jude Medical, Inc. sees FY2012 EPS of $3.42-3.44, versus the consensus of $3.43.
St. Jude Medical, Inc. sees Q4 2012 EPS of $0.86-0.88, versus the consensus of $0.89.
The company also announced plans to buyback up to $300 million in stock.
For earnings history and earnings-related data on St. Jude Medical, Inc. (STJ) click here.
St. Jude Medical, Inc. sees FY2012 EPS of $3.42-3.44, versus the consensus of $3.43.
St. Jude Medical, Inc. sees Q4 2012 EPS of $0.86-0.88, versus the consensus of $0.89.
The company also announced plans to buyback up to $300 million in stock.
For earnings history and earnings-related data on St. Jude Medical, Inc. (STJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Stock BuybacksRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
